- Pancreatic serous cystadenoma
Pancreatic serous cystadenoma Classification and external resources
Micrograph showing a pancreatic serous cystadenoma. H&E stain.
Pancreatic serous cystadenoma, also known as serous cystadenoma of the pancreas and serous microcystic adenoma, a benign tumour of pancreas. It is usually found in the tail of the pancreas, and may be associated with von Hippel-Lindau syndrome.
In contrast to some of the other cyst-forming tumors of the pancreas (such as the intraductal papillary mucinous neoplasm and the mucinous cystic neoplasm), serous cystic neoplasms are almost always entirely benign. There are some exceptions; rare case reports have described isolated malignant serous cystadenocarcinomas. In addition, serous cystic neoplasms slowly grow, and if they grow large enough they can press on adjacent organs and cause symptoms.
Pathologists classify serous cystic neoplasms into two broad groups. Those that are benign, that have not spread to other organs, are designated "serous cystadenoma." Serous cystadenomas can be further sub-typed into microcystic, oligocystic (or macrocystic), solid, mixed serous-endocrine neoplasm, and VHL-associated serous cystic neoplasm. This latter classification scheme is useful because it highlights the range of appearances and the clinical associations of these neoplasms. Serous cystic neoplasms that have spread ("metastasized") to another organ are considered malignant and are designated "serous cystadenocarcinoma."
Serous cystic neoplasms can come to clinical attention in a variety of ways. The most common symptoms are very non-specific and include abdominal pain, nausea and vomiting. In contrast to many of the other tumors of the pancreas, patients rarely develop jaundice (a yellowing of the skin and eyes caused by obstruction of the bile duct), or weight loss. These signs and symptoms are not specific for a serous cystic neoplasm, making it more difficult to establish a diagnosis. Doctors will therefore often order additional tests.
Once a doctor has reason to believe that a patient may have serous cystic neoplasm, he or she can confirm that suspicion using one of a number of imaging techniques. These include computerized tomography (CT), endoscopic ultrasound (EUS), and magnetic resonance cholangiopancreatography (MRCP). These tests will reveal a cystic mass within the pancreas. The cysts do not communicate with the larger pancreatic ducts. In some cases a fine needle aspiration (FNA) biopsy can be obtained to confirm the diagnosis. Fine needle aspiration biopsy can be performed through an endoscope at the time of endoscopic ultrasound, or it can be performed through the skin using a needle guided by ultrasound or CT scanning. A growing number of patients are now being diagnosed before they develop symptoms (asymptomatic patients). In these cases, the lesion in the pancreas is discovered accidentally (by chance) when the patient is being scanned (x-rayed) for another reason.
The treatment of choice is either surgery, or if the clinician is certain of the diagnosis and the lesion is small, careful observation. Surgery can include the removal of the head of the pancreas (a pancreaticoduodenectomy), removal of the body and tail of the pancreas (a distal pancreatectomy), or rarely removal of the entire pancreas (a total pancreatectomy). In selected cases the surgery can be performed using minimally invasive techniques such as laparoscopy.
- Ovarian serous cystadenoma
- Solid pseudopapillary neoplasm
- ^ Colonna, J.; Plaza, JA.; Frankel, WL.; Yearsley, M.; Bloomston, M.; Marsh, WL. (2008). "Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients". Pancreatology 8 (2): 135–41. doi:10.1159/000123606. PMID 18382099.
- ^ Eras, M.; Yenigun, M.; Acar, C.; Kumbasar, B.; Sar, F.; Bilge, T.. "Pancreatic involvement in Von Hippel-Lindau disease". Indian J Cancer 41 (4): 159–61. PMID 15659868.
- ^ Galanis C, Zamani A, Cameron JL, et al. (July 2007). "Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment". J. Gastrointest. Surg. 11 (7): 820–6. doi:10.1007/s11605-007-0157-4. PMID 17440789.
- ^ "Pathology of Neoplasms of the Pancreas". Johns Hopkins University. http://pathology.jhu.edu/pancreas/BasicTypes1.php. Retrieved 25 April 2010.
- ^ "Diagnostic tests". Johns Hopkins University. http://pathology.jhu.edu/pancreas/DiagTests.php. Retrieved 25 April 2010.
- ^ "Pancreatic Surgery". Johns Hopkins University. http://pathology.jhu.edu/pancreas/TreatmentSurgery.php. Retrieved 25 April 2010.
- ^ "Laproscopic Pancreatic Surgery". Johns Hopkins University. http://pathology.jhu.edu/pancreas/TreatmentLaparoscopic.php. Retrieved 25 April 2010.
Tumors: digestive system neoplasia (C15–C26/D12–D13, 150–159/211) GI tractUpper GI tractGastric carcinoma · Signet ring cell carcinoma · Gastric lymphoma (MALT lymphoma) · Linitis plasticaUpper and/or lower Accessoryexocrine pancreas: Adenocarcinoma · Pancreatic ductal carcinoma
cystic neoplasms: Serous microcystic adenoma · Intraductal papillary mucinous neoplasm · Mucinous cystic neoplasm · Solid pseudopapillary neoplasm
PeritoneumPrimary peritoneal carcinoma · Peritoneal mesothelioma · Desmoplastic small round cell tumorCategories:
- Digestive system neoplasia
Wikimedia Foundation. 2010.